FDA panel decided on Monday to leave Avandia on the market. Consumers with Type II diabetes can continue to purchase the drug, Avandia, despite recent study showing increased risk of heart attack. At the same time, the FDA panel recognized that the drug, Avandia, has been linked to increased heart attacks among patients. Some panelists recommend a black box warning to be printed on the drug...